The European Medicines Agency (EMA) approved on Wednesday (05) the vaccine against coronavirus (COVID-19) from Moderna in Europe. The immunizer developed in the United States becomes the second to be released on the continent to expand the disease control actions, despite the uncertainties about the virus variants. The final step is the approval by the European Commission, which should happen in the next few days. "EMA has recommended granting conditional marketing authorization for Moderna's Covid-19 vaccine to prevent coronavirus (Covid-19) disease in people over 18," the agency said.
This text was translated by machine from Brazilian Portuguese.